Formulation of dacarbazine-loaded cubosomes. Part III. physicochemical characterization

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1243-1249

  Bei, Di ^a   Zhang, Tao ^a   Murowchick, James B ^a   Youan, Bi Botti C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

cubosome; dacarbazine; thermal analysis; X ray diffraction

Indexed keywords

CUBOSOME; DACARBAZINE; NANOCARRIER; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ENCAPSULATION; FRAGMENTATION REACTION; FREEZE DRYING; LIGHT SCATTERING; MORPHOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERMAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY POWDER DIFFRACTION;

ANTINEOPLASTIC AGENTS; DACARBAZINE; DRUG COMPOUNDING; LIPOSOMES; NANOSTRUCTURES; PARTICLE SIZE;

EID: 78649906690     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9496-7     Document Type: Article

References (43)

1. DA Chiappetta AM Carcaboso C Bregni M Rubio G Bramuglia A Sosnik 2009 Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance AAPS PharmSciTech 10 1 1 6 10.1208/s12249-008-9168-z 19127436
2. BC Hancock G Zografi 1997 Characteristics and significance of the amorphous state in pharmaceutical systems J Pharm Sci 86 1 1 12 10.1021/js9601896 9002452
3. H Abdelkader OY Abdalla H Salem 2007 Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation AAPS PharmSciTech 8 4 E100 10.1208/pt0804100 18181521
4. S Kaewnopparat K Sansernluk D Faroongsarng 2008 Behavior of freezable bound water in the bacterial cellulose produced by Acetobacter xylinum: an approach using thermoporosimetry AAPS PharmSciTech 9 2 701 7 10.1208/s12249-008-9104-2 18523890
5. A Ghassempour H Rafati L Adlnasab Y Bashour H Ebrahimzadeh M Erfan 2007 Investigation of the solid state properties of amoxicillin trihydrate and the effect of powder pH AAPS PharmSciTech 8 4 E93 10.1208/pt0804093 18181553 (Pubitemid 350130489)
6. B Van Eerdenbrugh B Stuyven L Froyen J Van Humbeeck JA Martens P Augustijns, et al. 2009 Downscaling drug nanosuspension production: processing aspects and physicochemical characterization AAPS PharmSciTech 10 1 44 53 10.1208/s12249-008-9170-5 19148764
7. K Spieth R Kaufmann R Dummer C Garbe JC Becker A Hauschild, et al. 2008 Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG) Ann Oncol 19 4 801 6 10.1093/annonc/mdm565 18178958 (Pubitemid 351461054)
8. D Schadendorf S Ugurel B Schuler-Thurner FO Nestle A Enk EB Brocker, et al. 2006 Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG Ann Oncol 17 4 563 70 10.1093/annonc/mdj138 16418308
9. MB Lens TG Eisen 2003 Systemic chemotherapy in the treatment of malignant melanoma Expert Opin Pharmacother 4 12 2205 11 10.1517/14656566.4.12.2205 14640919 (Pubitemid 37541234)
10. MR Middleton JJ Grob N Aaronson G Fierlbeck W Tilgen S Seiter, et al. 2000 Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma J Clin Oncol 18 1 158 66 10623706
11. TA Connors PM Goddard K Merai WC Ross DE Wilman 1976 Tumour inhibitory triazenes: structural requirements for an active metabolite Biochem Pharmacol 25 3 241 6 10.1016/0006-2952(76)90207-0 1267820
12. JC Shah Y Sadhale DM Chilukuri 2001 Cubic phase gels as drug delivery systems Adv Drug Deliv Rev 47 2-3 229 50 10.1016/S0169-409X(01)00108-9 11311994 (Pubitemid 32324116)
13. JS Patton MC Carey 1979 Watching fat digestion Science (New York, NY) 204 4389 145 8
14. E Pebay-Peyroula G Rummel JP Rosenbusch EM Landau 1997 X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases Science (New York, NY) 277 5332 1676 81
15. EM Landau JP Rosenbusch 1996 Lipidic cubic phases: a novel concept for the crystallization of membrane proteins Proc Natl Acad Sci USA 93 25 14532 5 10.1073/pnas.93.25.14532 8962086 (Pubitemid 26419001)
16. RH Muller RD Petersen A Hommoss J Pardeike 2007 Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv Drug Deliv Rev 59 6 522 30 10.1016/j.addr.2007.04.012 17602783 (Pubitemid 47271894)
17. E Esposito N Eblovi S Rasi M Drechsler GM Di Gregorio E Menegatti, et al. 2003 Lipid-based supramolecular systems for topical application: a preformulatory study AAPS PharmSci 5 4 E30 10.1208/ps050430 15198518 (Pubitemid 38097475)
18. D Bei J Marszalek BB Youan 2009 Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables AAPS PharmSciTech 10 3 1032 9 10.1208/s12249-009-9293-3 19669896
19. D Bei J Marszalek BB Youan 2009 Formulation of dacarbazine-loaded cubosomes-part II: influence of process parameters AAPS PharmSciTech 10 3 1040 7 10.1208/s12249-009-9296-0 19688599
20. CF Hackley VaF 2001 The use of nomenclature in dispersion science and technology, NIST recommended practice guide SP 960 3 76
21. J Briggs H Chung M Caffrey 1996 The temperature composition phase diagram and mesophase structure characterization of the monoolein/water system J Phys II France 6 723 51 10.1051/jp2:1996208
22. H Qiu M Caffrey 2000 The phase diagram of the monoolein/water system: metastability and equilibrium aspects Biomaterials 21 3 223 34 10.1016/S0142-9612(99)00126-X 10646938
23. ES Lutton 1965 Phase behavior of aqueous systems of monoglycerides J Am Oil Chem Soc 42 12 1068 70 10.1007/BF02636909 5845647
24. W Longley TJ McIntosh 1983 A bicontinuous tetrahedral structure in a liquid-crystalline lipid Nature 303 612 4 10.1038/303612a0
25. ST Hyde S Anderson B Ericsson K Larsson 1984 A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glyceryl monooleate-water system Z Kristallogr 168 213 9 10.1524/zkri.1984.168.1-4.213
26. BJ Boyd 2003 Characterisation of drug release from cubosomes using the pressure ultrafiltration method Int J Pharm 260 2 239 47 10.1016/S0378-5173(03) 00262-X 12842343 (Pubitemid 36773921)
27. HC Freeman ND Hutchinson 1979 The crystal structure of the anti-tumor agent 5-(3, 3-dimethyl-1-triazenyl)imidazole-4-carboxamide (NSC-45388) Acta Cryst B 35 2051 10.1107/S0567740879008438
28. A Yaghmur P Laggner M Almgren M Rappolt 2008 Self-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition PLoS ONE 3 11 e3747 10.1371/journal.pone.0003747 19015726
29. E Esposito R Cortesi M Drechsler L Paccamiccio P Mariani C Contado, et al. 2005 Cubosome dispersions as delivery systems for percutaneous administration of indomethacin Pharm Res 22 12 2163 73 10.1007/s11095-005-8176-x 16267633 (Pubitemid 41821596)
30. TY Liu SH Hu KH Liu RS Shaiu DM Liu SY Chen 2008 Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field Langmuir 24 23 13306 11 10.1021/la801451v 18954093
31. T Landh 1994 Phase behavior in the system pine oil monoglycerides- poloxamer 407-water at 20 C J Phys Chem 98 8453 67 10.1021/j100085a028
32. Israelachvili JN. Intermolecular and surface forces. London, UK: Academic; 1991.
33. DM Anderson SM Gruner S Leibler 1988 Geometrical aspects of the frustration in the cubic phases of lyotropic liquid crystals Proc Natl Acad Sci USA 85 15 5364 8 10.1073/pnas.85.15.5364 3399497
34. B Siekmann H Bunjes MH Koch K Westesen 2002 Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases Int J Pharm 244 1-2 33 43 10.1016/S0378-5173(02)00298-3 12204563 (Pubitemid 35245444)
35. G Worle M Drechsler MH Koch B Siekmann K Westesen H Bunjes 2007 Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions Int J Pharm 329 1-2 150 7 10.1016/j.ijpharm.2006.08.023 16987623 (Pubitemid 44940847)
36. J Gustafsson H Ljusberg-Wahren M Almgren K Larsson 1997 Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer Langmuir 13 6964 71 10.1021/la970566+
37. SW Hui TP Stewart LT Boni PL Yeagle 1981 Membrane fusion through point defects in bilayers Science (New York, NY) 212 4497 921 3
38. I Amar-Yuli E Wachtel EB Shoshan D Danino A Aserin N Garti 2007 Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer Langmuir 23 7 3637 45 10.1021/la062851b 17328564 (Pubitemid 46581888)
39. WS Koegler C Patrick MJ Cima LG Griffith 2002 Carbon dioxide extraction of residual chloroform from biodegradable polymers J Biomed Mater Res 63 5 567 76 10.1002/jbm.10209 12209902
40. RJ Mumper M Jay 1992 Poly(L-lactic acid) microspheres containing neutron-activatable holmium-165: a study of the physical characteristics of microspheres before and after irradiation in a nuclear reactor Pharm Res 9 1 149 54 10.1023/A:1018908600711 1589401
41. C B'Hymer 2003 Residual solvent testing: a review of gas-chromatographic and alternative techniques Pharm Res 20 3 337 44 10.1023/A:1022693516409 12669951 (Pubitemid 36288361)
42. S Freitas HP Merkle B Gander 2005 Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology J Control Release 102 2 313 32 10.1016/j.jconrel.2004.10.015 15653154
43. SW Zielhuis JF Nijsen L Dorland GC Krijger AD van Het Schip WE Hennink 2006 Removal of chloroform from biodegradable therapeutic microspheres by radiolysis Int J Pharm 315 1-2 67 74 10.1016/j.ijpharm.2006.02.010 16549282 (Pubitemid 43674111)